Thu, September 19, 2024
[ 12:00 AM ] - WOPRAI
Wed, July 3, 2024
Thu, March 14, 2024
[ 12:00 AM ] - WOPRAI
Thu, February 22, 2024
[ 12:00 AM ] - WOPRAI
Tue, February 13, 2024
[ 12:00 AM ] - WOPRAI
Fri, February 9, 2024
[ 12:00 AM ] - WOPRAI
Fri, September 8, 2023
[ 12:00 AM ] - WOPRAI
Fri, February 3, 2023
[ 12:00 AM ] - WOPRAI
Fri, January 20, 2023
[ 12:00 AM ] - WOPRAI
Tue, January 17, 2023
[ 12:00 AM ] - WOPRAI
Mon, November 14, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, November 4, 2022
[ 12:00 AM ] - WOPRAI
Thu, October 20, 2022
[ 12:00 AM ] - WOPRAI
Mon, October 17, 2022
[ 12:00 AM ] - WOPRAI
Thu, August 11, 2022
[ 12:00 AM ] - WOPRAI
Fri, August 5, 2022
[ 12:00 AM ] - WOPRAI
Thu, August 4, 2022
[ 12:00 AM ] - WOPRAI
Thu, May 12, 2022
[ 12:00 AM ] - WOPRAI
Fri, March 18, 2022
[ 12:00 AM ] - WOPRAI
Wed, March 16, 2022
[ 12:00 AM ] - WOPRAI
Tue, March 15, 2022
[ 12:00 AM ] - WOPRAI
Tue, March 8, 2022
[ 12:00 AM ] - WOPRAI
Thu, December 16, 2021
[ 12:00 AM ] - WOPRAI
Mon, November 22, 2021
[ 12:00 AM ] - WOPRAI
Tue, November 16, 2021
[ 12:00 AM ] - WOPRAI
Mon, November 15, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, November 11, 2021
[ 12:00 AM ] - WOPRAI
Thu, November 4, 2021
Joseph Schwartz Maintained (APLT) at Buy with Increased Target to $14 on, Sep 19th, 2024
Joseph Schwartz of Leerink Partners, Maintained "Applied Therapeutics, Inc." (APLT) at Buy with Increased Target from $11 to $14 on, Sep 19th, 2024.
Joseph has made no other calls on APLT in the last 4 months.
There are 2 other peers that have a rating on APLT. Out of the 2 peers that are also analyzing APLT, 0 agree with Joseph's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Joseph
- Tim Lugo of "William Blair" Initiated at Buy on, Wednesday, July 31st, 2024
- Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $12 on, Wednesday, July 17th, 2024
Contributing Sources